Introduction

Managing uncooperative children during dental procedures remains a major hurdle for many clinicians. Intranasal dexmedetomidine paediatric sedation offers a non-invasive solution, especially when clinicians pair it with nitrous oxide. This combined approach reduces anxiety and movement effectively. Consequently, doctors can perform complex extractions and oral surgeries in an outpatient setting without resorting to general anesthesia. This study highlights the clinical success of combining these agents to manage difficult paediatric cases.

Efficacy of Intranasal Dexmedetomidine Paediatric Sedation

In this study, researchers evaluated 63 uncooperative children aged 6 to 12 years. They used 2 µg/kg of intranasal dexmedetomidine (DEX) spray as a preoperative sedative. This method achieved successful parental separation in 100% of cases. Furthermore, over 95% of patients successfully completed their oral procedures. Most children maintained a moderate depth of sedation throughout the session. Therefore, the combination appears highly reliable for clinical use in outpatient dentistry.

Clinicians observed a significant decrease in heart rate and blood pressure after DEX administration. However, these changes remained within safe physiological ranges and required no intervention. Postoperatively, the most common adverse event was vomiting. This occurred in approximately 27% of the patients. Thus, medical teams must monitor patients carefully during the recovery phase to manage any nausea effectively.

Advantages of Spray Delivery

Nasal spray delivery provides better patient acceptance than traditional drops administered via a syringe. It ensures rapid absorption through the nasal mucosa and avoids the psychological trauma of needle insertion. Additionally, it provides a more predictable onset of action. Consequently, this method is gaining popularity in Indian dental clinics for difficult procedures. For instance, dentists use it for impacted tooth extractions and other complex surgeries frequently.

Frequently Asked Questions

What is the success rate of this sedation method?

In the clinical study, 95.24% of uncooperative children successfully completed their oral procedures using the intranasal dexmedetomidine and nitrous oxide combination.

Are there significant side effects to watch for?

The primary side effects include a temporary decrease in heart rate and blood pressure, along with postoperative vomiting in about 27% of cases. Respiratory depression is rarely reported with this specific regimen.

Why choose intranasal spray over other routes?

The intranasal route is non-invasive, avoids the use of needles, and has higher bioavailability than oral routes. Ready-to-use sprays are generally better tolerated and accepted by children than nasal drops.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Xiao YJ et al. The Efficacy and Safety of Intranasal Dexmedetomidine Spray Followed by Nitrous Oxide for Paediatric Oral Procedures. Int Dent J. 2026 May 20. doi: undefined. PMID: 42160811.

2. Unkel JH, et al. Effectiveness of intranasal dexmedetomidine with nitrous oxide compared to other pediatric dental sedation drug regimens. Pediatr Dent. 2021;43(6):457-462.

3. Sharma A. Safety and Efficacy of Intranasal Dexmedetomidine Compared to Midazolam in Pediatric Surgical Patients. Impactfactor. 2024; Jun 23.